Dow Jones

38,711.29

0.36%

Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.

Regístrate

Inicio
Invertir
Acciones
Canadá
TSX
ProMIS Neurosciences Inc (PMN)
ProMIS Neurosciences Inc (PMN) Noticias

PMN

ProMIS Neurosciences (PMN)

ProMIS Neurosciences Inc

Fecha:

Regulatory News

Text Search:

Ordernar por:

Non-Regulatory News

Showing the most relevant articles for your search:TSX:PMN

1 2 3 4 5 Próxima >

Fecha	Hora	Fuente	Título	Símbolo	Compañía
18/04/2022	08:05	PR Newswire (US)	Argus Research Initiates Equity Report Coverage on ProMIS Neurosciences, Inc. (TSX:PMN & OTCQB: ARFXF)	TSX:PMN	ProMIS Neurosciences Inc
18/08/2021	07:15	PR Newswire (Canada)	L'OCRCVM permet la reprise de la négociation - PMN	TSX:PMN	ProMIS Neurosciences Inc
18/08/2021	07:13	PR Newswire (Canada)	IIROC Trade Resumption - PMN	TSX:PMN	ProMIS Neurosciences Inc
17/08/2021	15:53	PR Newswire (Canada)	Suspension de la négociation par l'OCRCVM - PMN	TSX:PMN	ProMIS Neurosciences Inc
17/08/2021	15:50	PR Newswire (Canada)	IIROC Trading Halt - PMN	TSX:PMN	ProMIS Neurosciences Inc
18/11/2019	06:30	PR Newswire (Canada)	ProMIS Neurosciences Completes First Closing of Private Placement	TSX:PMN	ProMIS Neurosciences Inc
14/11/2019	06:30	PR Newswire (Canada)	ProMIS Neurosciences Announces Third Quarter 2019 Results	TSX:PMN	ProMIS Neurosciences Inc
13/11/2019	06:30	PR Newswire (Canada)	ProMIS Neurosciences Undertaking $6.5M Private Placement	TSX:PMN	ProMIS Neurosciences Inc
07/11/2019	06:30	PR Newswire (US)	ProMIS Neurosciences outlines best-in-class approach to amyloid-beta-targeting drug candidates for Alzheimer's disease	TSX:PMN	ProMIS Neurosciences Inc
24/10/2019	02:00	PR Newswire (US)	ProMIS Neurosciences issues Chairman's update memorandum and white paper on Alzheimer's disease	TSX:PMN	ProMIS Neurosciences Inc
23/10/2019	08:49	PR Newswire (US)	ProMIS Neurosciences advances ALS program selectively targeting toxic form of TDP-43	TSX:PMN	ProMIS Neurosciences Inc
17/10/2019	06:30	PR Newswire (US)	ProMIS Neurosciences advances Alzheimer's disease program targeting neurotoxic forms of tau	TSX:PMN	ProMIS Neurosciences Inc
08/10/2019	06:30	PR Newswire (US)	ProMIS Neurosciences Identifies Novel Antibody Candidates for Multiple System Atrophy	TSX:PMN	ProMIS Neurosciences Inc
03/09/2019	06:30	PR Newswire (US)	ProMIS Neurosciences to Present at HC Wainwright Investment Conference	TSX:PMN	ProMIS Neurosciences Inc
27/08/2019	06:30	PR Newswire (Canada)	ProMIS Neurosciences Appoints Internationally Recognized Researcher in Alzheimer's Disease in Down Syndrome Dr. Andre Strydom...	TSX:PMN	ProMIS Neurosciences Inc
13/08/2019	06:30	PR Newswire (Canada)	ProMIS Neurosciences Announces Second Quarter 2019 Results	TSX:PMN	ProMIS Neurosciences Inc
24/07/2019	06:30	PR Newswire (Canada)	ProMIS Neurosciences Announces Results of Annual Meeting of Shareholders	TSX:PMN	ProMIS Neurosciences Inc
18/07/2019	14:00	PR Newswire (US)	ProMIS Neurosciences Highlights Data for PMN310 at AAIC 2019	TSX:PMN	ProMIS Neurosciences Inc
10/07/2019	06:30	PR Newswire (Canada)	ProMIS Neurosciences to Present Data at 2019 Alzheimer's Association International Conference	TSX:PMN	ProMIS Neurosciences Inc
09/07/2019	06:30	PR Newswire (US)	ProMIS Neurosciences' Data for Alzheimer's Disease Clinical Candidate PMN310 Published in Scientific Reports	TSX:PMN	ProMIS Neurosciences Inc
27/06/2019	06:30	PR Newswire (Canada)	ProMIS Neurosciences' PMN310 Shows Greater Therapeutic Potential vs. Other Amyloid-Beta-Directed Antibodies	TSX:PMN	ProMIS Neurosciences Inc
26/06/2019	06:30	PR Newswire (Canada)	ProMIS Neurosciences Closing Private Placement	TSX:PMN	ProMIS Neurosciences Inc
19/06/2019	06:30	PR Newswire (US)	ProMIS Neurosciences Appoints Renowned Parkinson's Disease Expert Dr. C. Warren Olanow to Scientific Advisory Board	TSX:PMN	ProMIS Neurosciences Inc
05/06/2019	06:30	PR Newswire (US)	ProMIS Neurosciences Presents Lead Program for Alzheimer's Disease at Prestigious Keystone Symposia Scientific Conference	TSX:PMN	ProMIS Neurosciences Inc
29/05/2019	06:30	PR Newswire (US)	ProMIS Neurosciences' Eugene Williams to Present at JLABS' Conference on Innovations in Neurodegenerative Diseases	TSX:PMN	ProMIS Neurosciences Inc
28/05/2019	06:30	PR Newswire (US)	ProMIS Neurosciences Identifies Novel Antibodies for Alzheimer's Disease with Selectivity for the Neurotoxic Form of Tau	TSX:PMN	ProMIS Neurosciences Inc
14/05/2019	06:30	PR Newswire (US)	ProMIS Neurosciences Announces First Quarter 2019 Results	TSX:PMN	ProMIS Neurosciences Inc
23/04/2019	06:30	PR Newswire (US)	ProMIS Neurosciences to Participate in the Think Equity Investor Conference	TSX:PMN	ProMIS Neurosciences Inc
26/03/2019	06:30	PR Newswire (US)	ProMIS Neurosciences to Participate in Microcap Spring Investor Summit 2019	TSX:PMN	ProMIS Neurosciences Inc
21/03/2019	13:47	PR Newswire (US)	Aducanumab Failure: Selectivity for the Toxic Oligomer is Essential to Treating Root Cause of Alzheimer's Disease	TSX:PMN	ProMIS Neurosciences Inc